| Qutenza (capsaicin) / Grunenthal, LTS Lohmann Therapy Systems |
2012-002406-46: Comparison of different Capsaicin doses and their effects on nerve fibres in the skin Vergleich unterschiedlicher Capsaicin Dosierungen und ihr Einfluss auf die Nervenfasern in der Haut |
|
|
| Ongoing | 4 | 12 | Europe | Qutenza, Capsaicin 0,05% Ointment, N01BX04, Qutenza, Qutenza | Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie, Medizinische Universität Wien | Impact of Capsaicin on epidermal nerve fibres Einfluss von Capsaicin auf epidermale Nervenfasern | | | | |
| Ongoing | 4 | 20 | Europe | Qutenza, Qutenza, Qutenza | Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie, Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie | Pain | | | | |
2017-004746-17: Treatment of nerve pain in patients with diabetes with a capsaicin (chilli pepper) patch (skin plaster). |
|
|
| Ongoing | 4 | 50 | Europe | Qutenza (Capsaicin) 8 % patch, Cutaneous patch, Qutenza (Capsaicin) 8 % patch | Joint Research Compliance Office, Imperial College London and Imperial College Healthcare NHS Trust, Diabetes UK | Diabetic painful neuropathy, Nerve damage with pain in patients with diabetes, Diseases [C] - Nervous System Diseases [C10] | | | | |
2018-003617-17: Localized neuropathic pain: topical treatment versus systemic treatment |
|
|
| Not yet recruiting | 4 | 591 | Europe | Cutaneous patch, Capsule, hard, Lidocaïne Grünenthal 700 mg pleister (Versatis), Capsaicine (Qutenza) 179 mg huidpleister, Pregabaline (Lyrica) 75 mg harde capsules | Antwerp University Hospital (UZA), Belgian Health Care Knowledge Center (KCE) | Patients suffering from localized neuropathic pain (LNP), Patients suffering from localized neuropathic pain (LNP), Diseases [C] - Nervous System Diseases [C10] | | | | |
2020-001022-57: Treatment with small Qutenza patches over painful trigger points in scars after operation: A blinded study using placebo paths versus active Qutenza patch |
|
|
| Not yet recruiting | 4 | 26 | Europe | Qutenza 179 mg cutaneous patch, EMEA/H/C/00909, Cutaneous patch, Qutenza 179 mg kutanplaster | Wojciech Zbigniew Pawlak | Post-operative neuropathic pain, Pain after nerve damage, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Not yet recruiting | 4 | 120 | Europe | Capsaicin 179 Mg Cutaneous Patch, QUTENZA, Capsaicine low dose 0.04 %, control treatment | University Hospital, Clermont-Ferrand, Grünenthal GmbH | Osteoarthritis Hand, Neuropathic Pain | 01/28 | 01/28 | | |
2018-003559-39: multicentric Study , open, randomized, comparing the topical treatment by patch of capsaïcine with 8 % ( Qutenza) to the oral prégabaline treatment in the early treatment of the neuropathic pains after a primary surgery for breast cancer ( CAPTRANE) Etude multicentrique, ouverte, randomisée, comparant le traitement topique par patch de capsaïcine à 8% (Qutenza) à la prégabaline per os dans le traitement précoce des douleurs neuropathiques après une chirurgie primaire pour cancer du sein (CAPTRANE) |
|
|
| Not yet recruiting | 3 | 772 | Europe | Cutaneous patch, Capsule, QUTENZA, PREGABALINE | INSTITUT DE CANCEROLOGIE DE L'OUEST, GRUNENTHAL | men and /or women older than 18 years with breast cancer for which a surgical operation was realized. homme et/ou femme de plus de 18 ans, atteint d’un cancer du sein pour lequel une intervention chirurgicale a été réalisée., men and /or women older than 18 years with breast cancer for which a surgical operation was realized. homme et/ou femme de plus de 18 ans, atteint d’un cancer du sein pour lequel une intervention chirurgicale a été réalisée., Diseases [C] - Cancer [C04] | | | | |
2021-001409-64: A multi site clinical trial to evaluate the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain Un ensayo clínico en varios centros para evaluar la eficacia y seguridad de Qutenza® en pacientes con dolor neuropático posquirúrgico |
|
|
| Not yet recruiting | 3 | 510 | Europe | Capsaicin, Cutaneous patch, Qutenza | Averitas Pharma, Inc., Averitas Pharma, Inc. | Post-surgical neuropathic pain (PSNP) Dolor neuropático posquirúrgico (DNPQ), Post-surgical neuropathic pain (PSNP) Dolor neuropático posquirúrgico (DNPQ), Body processes [G] - Physiological processes [G07] | | | | |
| Completed | 3 | 140 | Europe | Capsaicin, qutenza EU/1/09/524/001, Pregabalin, Lyrica | Institut Cancerologie de l'Ouest, Grünenthal GmbH | Breast Cancer Patient | 11/22 | 11/22 | | |
NCT04967664: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery |
|
|
| Active, not recruiting | 3 | 409 | Europe, US | Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system | Averitas Pharma, Inc. | Post Surgical Neuropathic Pain | 01/25 | 08/25 | | |
CAPSACOX, NCT06023706: Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia. |
|
|
| Recruiting | 3 | 188 | Europe | Capsaicin 179 Mg Cutaneous Patch, qutenza, Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2) | Nantes University Hospital | Coccyx Disorder, Neuropathic Pain, Coccygodynia | 01/27 | 06/27 | | |
CAPNEUCHIM, NCT05840562: Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy |
|
|
| Recruiting | 3 | 274 | Europe | Capsaicin, Qutenza, Duloxetine, Cymbalta | Institut Cancerologie de l'Ouest, Grünenthal GmbH | Chemotherapy-induced Peripheral Neuropathy | 03/27 | 03/27 | | |
2020-003965-21: Phase II Randomized Controlled Study Aiming to Evaluate the Interest of Qutenza in Patients With ORL Cancer in Remission and With Sequellae Neuropathic Pain. Phase II randomisée comparative visant à évaluer l’intérêt du Qutenza dans la prise en charge de patients en rémission de cancer ORL et présentant des douleurs neuropathiques séquellaires. |
|
|
| Not yet recruiting | 2 | 130 | Europe | Cutaneous patch, Oral solution, Qutenza®, Laroxyl® | INSTITUT CLAUDIUS REGAUD, DGOS | Head and neck cancer Cancer ORL, Head and neck cancer Cancer ORL, Diseases [C] - Cancer [C04] | | | | |
NCT03464292: Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia |
|
|
| Completed | 2 | 55 | US | Capsaicin Patch 8% or 0.1% Capsaicin Cream, Qutenza, Capsaicin No-Fuss, Vehicle Patch | University of Florida | Fibromyalgia, Pain | 07/23 | 12/23 | | |
TEC-ORL, NCT04704453: Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. |
|
|
| Recruiting | 2 | 130 | Europe | Capsaïcin patch (Qutenza®), Amitriptyline (Laroxyl®) | Institut Claudius Regaud | Head and Neck Cancer | 01/26 | 01/26 | | |
| Recruiting | 2 | 46 | Europe | Capsaicin 8% patch, QUTENZA®, Hydrocolloid dressing, COMFEEL PLUS TRANSPARENT | University Hospital, Brest | Neuropathic Pain, Chronic Pain | 04/26 | 04/26 | | |
NCT06197529: Is Nociceptive Processing Evoked by Heat Homeostatically Regulated: A Contact-heat Evoked Potentials Study |
|
|
| Completed | N/A | 18 | Europe | Homeostatic Plasticity, Topical alone (Capsaicin 8% Patch), Qutenza Capsaicin (8%), Placebo Patch, Homeostatic Plasticity (Sham) | Aalborg University | Healthy | 03/24 | 03/24 | | |
| Recruiting | N/A | 120 | Europe | Osteopathic treatment, Capsaicin QUTENZA Patch (TAU) | Institut Toulousain d'Ostéopathie, Institut Claudius Regaud | Breast Cancer, Neuropathic Pain | 12/23 | 12/24 | | |
| Not yet recruiting | N/A | 106 | NA | Capsaicin, Capsaicin 8% patch | Nantes University Hospital | Coccyx Disorder | 12/23 | 12/23 | | |
NCT06495424: Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy |
|
|
| Not yet recruiting | N/A | 150 | US | Capsaicin 8% Patch Kit,1 | Averitas Pharma, Inc. | Peripheral Diabetic Neuropathy, Painful Diabetic Neuropathy | 06/25 | 12/25 | | |
NCT06540456: Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy |
|
|
| Enrolling by invitation | N/A | 50 | US | Qutenza® 8% Capsaicin Topical System | Medical University of South Carolina, Averitas Pharma, Inc. | Lower Back Pain, Lumbosacral Radiculopathy | 07/27 | 07/28 | | |
QULOX, NCT05560516: Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN) |
|
|
| Recruiting | N/A | 102 | Europe | Qutenza, Duloxetine | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Leiden University Medical Center, Reinier de Graaf | Qutenza, Duloxetine, Chemotherapy-induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy | 12/24 | 12/25 | | |
| ZYN001 / LTS Lohmann Therapy Systems, Paragon Biosci |
| No trials found |
| asenapine transdermal patch / LTS Lohmann Therapy Systems, Livzon Pharma |
| No trials found |
